BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7662136)

  • 21. Differential inhibition of human basal keratinocyte growth to silver sulfadiazine and mafenide acetate.
    McCauley RL; Li YY; Poole B; Evans MJ; Robson MC; Heggers JP; Herndon DN
    J Surg Res; 1992 Mar; 52(3):276-85. PubMed ID: 1538606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2.5% Mafenide Acetate: A Cost-Effective Alternative to the 5% Solution for Burn Wounds.
    Afshari A; Nguyen L; Kahn SA; Summitt B
    J Burn Care Res; 2017; 38(1):e42-e47. PubMed ID: 27606553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mafenide acetate allergy presenting as recurrent chondritis.
    Pickus EJ; Lionelli GT; Charles EW; Korentager RA
    Ann Plast Surg; 2002 Feb; 48(2):202-4. PubMed ID: 11910229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity to silver in a patient treated with silver sulphadiazine (Flamazine).
    Fraser-Moodie A
    Burns; 1992 Feb; 18(1):74-5. PubMed ID: 1558683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silver sulphadiazine-induced haemolytic anaemia in a glucose-6-phosphate dehydrogenase-deficient burn patient.
    Eldad A; Neuman A; Weinberg A; Benmeir P; Rotem M; Wexler MR
    Burns; 1991 Oct; 17(5):430-2. PubMed ID: 1760119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective double-blinded comparative analysis of framycetin and silver sulphadiazine as topical agents for burns: a pilot study.
    Ahuja RB; Gupta A; Gur R
    Burns; 2009 Aug; 35(5):672-6. PubMed ID: 19443125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient leukopenia associated with topical silver sulfadiazine in burn therapy.
    Gbaanador GB; Policastro AJ; Durfee D; Bleicher JN
    Nebr Med J; 1987 Mar; 72(3):83-5. PubMed ID: 3561596
    [No Abstract]   [Full Text] [Related]  

  • 28. Methaemoglobinaemia induced by mafenide acetate in children. A report of two cases.
    Ohlgisser M; Adler M; Ben-Dov D; Taitelman U; Birkhan HJ; Bursztein S
    Br J Anaesth; 1978 Mar; 50(3):299-301. PubMed ID: 638002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of the pain produced by mafenide acetate preparations in burns.
    Harrison HN; Shuck JM; Caldwell E
    Arch Surg; 1975 Dec; 110(12):1446. PubMed ID: 981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of 5% mafenide acetate solution on bacterial control in infected rat burns.
    Murphy RC; Kucan JO; Robson MC; Heggers JP
    J Trauma; 1983 Oct; 23(10):878-81. PubMed ID: 6415293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current treatment recommendations for topical burn therapy.
    Monafo WW; West MA
    Drugs; 1990 Sep; 40(3):364-73. PubMed ID: 2226220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of topical therapy of the burn wound with silver sulphadiazine after its use for 15 years in a burn unit.
    Koo DS; Zhen S; Zhen ZD; Shi XW; Xiang SJ
    Burns; 1989 Jun; 15(3):193-6. PubMed ID: 2757770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In-vitro efficacy of topical antibiotics on bacteria from burns].
    Baars B; Opferkuch W; Müller FE
    Fortschr Med; 1980 Mar; 98(11):400-2. PubMed ID: 6768661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver.
    Klasen HJ
    Burns; 2000 Mar; 26(2):131-8. PubMed ID: 10716355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical therapy.
    Monafo WW; Ayvazian VH
    Surg Clin North Am; 1978 Dec; 58(6):1157-71. PubMed ID: 734607
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypercarbia and acidosis associated with carbonic anhydrase inhibition: a hazard of topical mafenide acetate use in renal failure.
    Liebman PR; Kennelly MM; Hirsch EF
    Burns Incl Therm Inj; 1982 Jul; 8(6):395-8. PubMed ID: 6809230
    [No Abstract]   [Full Text] [Related]  

  • 37. Febrile reaction to silver sulphadiazine cream.
    Clarke SD; Gallur L; Threlfall GN
    Med J Aust; 1981 Aug; 2(4):208. PubMed ID: 7300733
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro toxicity of topical antimicrobial agents to human fibroblasts.
    McCauley RL; Linares HA; Pelligrini V; Herndon DN; Robson MC; Heggers JP
    J Surg Res; 1989 Mar; 46(3):267-74. PubMed ID: 2921865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Our experience with the use of cerium sulphadiazine in the treatment of extensive burns.
    Koller J; Orsag M
    Acta Chir Plast; 1998; 40(3):73-5. PubMed ID: 9782621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of drugs in management of burns.
    Pegg SP
    Drugs; 1982 Sep; 24(3):256-60. PubMed ID: 7128481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.